1. Home
  2. BIAF vs QH Comparison

BIAF vs QH Comparison

Compare BIAF & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • QH
  • Stock Information
  • Founded
  • BIAF 2014
  • QH 2012
  • Country
  • BIAF United States
  • QH China
  • Employees
  • BIAF N/A
  • QH N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • QH Business Services
  • Sector
  • BIAF Health Care
  • QH Consumer Discretionary
  • Exchange
  • BIAF Nasdaq
  • QH Nasdaq
  • Market Cap
  • BIAF 7.6M
  • QH 6.6M
  • IPO Year
  • BIAF 2022
  • QH 2020
  • Fundamental
  • Price
  • BIAF $0.15
  • QH $6.18
  • Analyst Decision
  • BIAF Hold
  • QH
  • Analyst Count
  • BIAF 1
  • QH 0
  • Target Price
  • BIAF N/A
  • QH N/A
  • AVG Volume (30 Days)
  • BIAF 12.0M
  • QH 88.7K
  • Earning Date
  • BIAF 11-13-2025
  • QH 08-28-2025
  • Dividend Yield
  • BIAF N/A
  • QH N/A
  • EPS Growth
  • BIAF N/A
  • QH N/A
  • EPS
  • BIAF N/A
  • QH 0.80
  • Revenue
  • BIAF $7,681,059.00
  • QH $417,431,053.00
  • Revenue This Year
  • BIAF N/A
  • QH N/A
  • Revenue Next Year
  • BIAF $20.04
  • QH N/A
  • P/E Ratio
  • BIAF N/A
  • QH $8.35
  • Revenue Growth
  • BIAF 4.99
  • QH N/A
  • 52 Week Low
  • BIAF $0.16
  • QH $3.93
  • 52 Week High
  • BIAF $2.26
  • QH $169.07
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 33.56
  • QH 26.17
  • Support Level
  • BIAF $0.24
  • QH $6.01
  • Resistance Level
  • BIAF $0.45
  • QH $7.07
  • Average True Range (ATR)
  • BIAF 0.03
  • QH 0.55
  • MACD
  • BIAF -0.01
  • QH 2.62
  • Stochastic Oscillator
  • BIAF 5.79
  • QH 67.64

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.

Share on Social Networks: